BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30890818)

  • 21. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.
    Obirikorang C; Acheampong E; Quaye L; Yorke J; Amos-Abanyie EK; Akyaw PA; Anto EO; Bani SB; Asamoah EA; Batu EN
    PLoS One; 2020; 15(1):e0227779. PubMed ID: 31929604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE, APOA5, and MTP Gene Polymorphisms Analysis in Relation to Triglyceride and Insulin Levels in Pediatric Patients.
    Carranza-González L; León-Cachón RBR; González-Zavala MA; Ríos-Ibarra C; Morlett-Chávez J; Sánchez-Domínguez C; Cepeda-Nieto A; Salinas-Santander M
    Arch Med Res; 2018 Feb; 49(2):94-100. PubMed ID: 29705673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Methylenetetrahydrofolate Reductase C677T (rs1801133) and Apolipoprotein A5-1131T>C (rs662799) Polymorphisms, and Anemia Are Independent Risk Factors for Ischemic Stroke.
    Escobedo J; Paz-Aragón E; Vega-Rodríguez LH; Benítez Sanfeliz MA; Estrada-Rodríguez H; González-Figueroa E; Liceaga-Craviotto MG; Gutiérrez-Cuevas J; Valladares-Salgado A; Cruz M
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1357-1362. PubMed ID: 29398535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast Mexico.
    Ovando Gómez V; Zavaleta Muñiz SA; Ochoa-Díaz-López H; Hernández Contreras JAC; Irecta Nájera CA
    Clin Investig Arterioscler; 2023; 35(2):53-63. PubMed ID: 35961839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram developed with
    Abulaiti D; Abudureyimu S; Li H; Cao Y; Gao Y
    Cardiovasc Diagn Ther; 2024 Feb; 14(1):118-128. PubMed ID: 38434565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.
    Jacob J; Boczkowska S; Zaluska W; Buraczynska M
    BMC Nephrol; 2022 Sep; 23(1):307. PubMed ID: 36071387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis.
    Mozafari S; Ashoori M; Emami Meybodi SM; Solhi R; Mirjalili SR; Firoozabadi AD; Soltani S
    BMC Genomics; 2024 Jun; 25(1):590. PubMed ID: 38867151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of apolipoprotein A5 T-1131C and apolipoprotein E common genetic variants on the levels of hemostatic markers in dyslipidemic patients.
    Novotny D; Karasek D; Vaverkova H; Slavik L
    Clin Chim Acta; 2014 Sep; 436():11-7. PubMed ID: 24815086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Association between Different Metabolic Variants in
    Bakhashab S; Alsulami T; Gusti AMT; Harakeh S; Al-Raddadi R; Alwazani WA; Alshaibi HF
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in adiposity modulate the APOA5 genetic effect on blood lipids: A longitudinal cohort study.
    Lin H; Xuan L; Xiang J; Hou Y; Dai H; Wang T; Zhao Z; Wang S; Lu J; Xu Y; Chen Y; Wang W; Ning G; Bi Y; Li M; Xu M
    Atherosclerosis; 2022 Jun; 350():1-8. PubMed ID: 35461093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children.
    Suárez-Sánchez F; Klunder-Klunder M; Valladares-Salgado A; Gómez-Zamudio J; Peralta-Romero J; Meyre D; Burguete-García A; Cruz M
    Pediatr Obes; 2017 Aug; 12(4):330-336. PubMed ID: 27171122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.
    Ferreira CN; Carvalho MG; Fernandes AP; Santos IR; Rodrigues KF; Lana AM; Almeida CR; Loures-Vale AA; Gomes KB; Sousa MO
    Gene; 2013 Mar; 516(1):171-5. PubMed ID: 23266809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients.
    Lakbakbi El Yaagoubi F; Charoute H; Bakhchane A; Ajjemami M; Benrahma H; Errouagui A; Kandil M; Rouba H; Barakat A
    Pathol Biol (Paris); 2015 Dec; 63(6):243-7. PubMed ID: 26524954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study.
    Zhu Y; Zhang D; Zhou D; Li Z; Li Z; Fang L; Yang M; Shan Z; Li H; Chen J; Zhou X; Ye W; Yu S; Li H; Cai L; Liu C; Zhang J; Wang L; Lai Y; Ruan L; Sun Z; Zhang S; Wang H; Liu Y; Xu Y; Ling J; Xu C; Zhang Y; Lv D; Yuan Z; Zhang J; Zhang Y; Shi Y; Lai M
    J Cell Mol Med; 2017 Jun; 21(6):1106-1116. PubMed ID: 28371326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
    Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
    PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FTO rs9939609 "A" allele is associated with impaired fasting glucose and insulin resistance in Emirati population.
    Saber-Ayad M; Manzoor S; El Serafi A; Mahmoud I; Hammoudeh S; Rani A; Abusnana S; Sulaiman N
    Gene; 2019 Jan; 681():93-98. PubMed ID: 30273662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions.
    Fenwick PH; Jeejeebhoy K; Dhaliwal R; Royall D; Brauer P; Tremblay A; Klein D; Mutch DM
    Crit Rev Food Sci Nutr; 2019; 59(13):2028-2039. PubMed ID: 29400991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.